| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |